1109 related articles for article (PubMed ID: 1720808)
21. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
22. In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors.
Mingari MC; Poggi A; Biassoni R; Bellomo R; Ciccone E; Pella N; Morelli L; Verdiani S; Moretta A; Moretta L
J Exp Med; 1991 Jul; 174(1):21-6. PubMed ID: 1711562
[TBL] [Abstract][Full Text] [Related]
23. Sideways killing: the cytolysis of Fc receptor-bearing cells through bridging to cytolytic T lymphocytes by antibodies specific for the T-cell receptor-T3 complex.
Ito M; Usuba O; Unkeless JC; Schreiber R; Celada F; Bona CA; Moran TM
Scand J Immunol; 1989 Jun; 29(6):659-69. PubMed ID: 2525807
[TBL] [Abstract][Full Text] [Related]
24. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
25. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones.
Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L
Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900
[TBL] [Abstract][Full Text] [Related]
26. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
[TBL] [Abstract][Full Text] [Related]
27. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
[TBL] [Abstract][Full Text] [Related]
28. A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).
Ciccone E; Ferrini S; Bottino C; Viale O; Prigione I; Pantaleo G; Tambussi G; Moretta A; Moretta L
J Exp Med; 1988 Jul; 168(1):1-11. PubMed ID: 2456364
[TBL] [Abstract][Full Text] [Related]
29. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
[TBL] [Abstract][Full Text] [Related]
30. Human T lymphocytes expressing gamma/delta T cell antigen receptor.
Moretta L; Ciccone E; Mingari MC; Bottino C; Ferrini S; Tambussi G; Melioli G; Grossi CE; Moretta A
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S117-23. PubMed ID: 2521314
[TBL] [Abstract][Full Text] [Related]
31. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
[TBL] [Abstract][Full Text] [Related]
32. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
33. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
Gramzinski RA; Adams E; Gross JA; Goodman TG; Allison JP; Lefrançois L
Int Immunol; 1993 Feb; 5(2):145-53. PubMed ID: 8383994
[TBL] [Abstract][Full Text] [Related]
34. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes.
Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L
Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830
[TBL] [Abstract][Full Text] [Related]
35. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
Koyasu S
J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
[TBL] [Abstract][Full Text] [Related]
36. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
[TBL] [Abstract][Full Text] [Related]
37. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion.
Saverino D; Tenca C; Zarcone D; Merlo A; Megiovanni AM; Valle MT; Manca F; Grossi CE; Ciccone E
J Immunol; 1999 Jan; 162(2):651-8. PubMed ID: 9916682
[TBL] [Abstract][Full Text] [Related]
38. Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.
Bottino C; Tambussi G; Ferrini S; Ciccone E; Varese P; Mingari MC; Moretta L; Moretta A
J Exp Med; 1988 Aug; 168(2):491-505. PubMed ID: 2970517
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytes.
Ferrini S; Prigione I; Bottino C; Ciccone E; Tambussi G; Mammoliti S; Moretta L; Moretta A
Eur J Immunol; 1989 Jan; 19(1):57-61. PubMed ID: 2784109
[TBL] [Abstract][Full Text] [Related]
40. Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
Ferrini S; Cambiaggi A; Cantoni C; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
Int J Cancer Suppl; 1992; 7():15-8. PubMed ID: 1428398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
